🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase III non-inferiority trial targeting a specific subset...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-31
Trial ID
NCT07432178
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
This is a 2-arm parallel pragmatic randomized controlled trial that will co...
Status
Completed
Location
Jaseng Hospital of Korean Medicine
Start Date
2021-07-09
Trial ID
NCT04833270
Treatments Being Tested
Our main hypothesis is that acute EVT associated with best medical treatmen...
Status
Recruiting
Location
Department of Neurology/ Stroke Unit, Hôpital Gui de Chauliac
Start Date
2024-08-19
Trial ID
NCT05832762
Treatments Being Tested
This study is a randomized controlled, open-label, multicenter phase III cl...
Status
Recruiting
Location
Erwei Song
Start Date
2023-12-01
Trial ID
NCT06079983
This Phase III, randomized, open-label, multicenter study will evaluate the...
Status
Active Not Recruiting
Location
Alaska Oncology & Hematology, LLC
Start Date
2022-08-03
Trial ID
NCT05306340
Treatments Being Tested
Evaluation of the efficacy of the combination of olaparib and trabectedin i...
Status
Completed
Location
Medizinische Fakultät der TU Dresden
Start Date
2018-10-25
Trial ID
NCT03127215
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
Melanoma remains a common cancer with rising incidence, and despite signifi...
Status
Not Yet Recruiting
Location
HFR Fribourg
Start Date
2026-09
Trial ID
NCT07574047
Treatments Being Tested
This is a Phase III, global, randomized, open-label, multicenter, study eva...
Status
Active Not Recruiting
Location
Southern Cancer Center
Start Date
2021-08-27
Trial ID
NCT04961996
Treatments Being Tested